![]() ![]() Narbutas, Justinas ![]() ![]() ![]() Poster (2018, September) Detailed reference viewed: 29 (8 ULiège)![]() ![]() Van Egroo, Maxime ![]() ![]() ![]() Conference (2018, September) Detailed reference viewed: 41 (3 ULiège)![]() ![]() Chylinski, Daphné ![]() ![]() Conference (2018, September) Detailed reference viewed: 33 (10 ULiège)![]() ![]() Van Egroo, Maxime ![]() ![]() ![]() Poster (2018, March 22) Detailed reference viewed: 18 (3 ULiège)![]() Bornheim, Stephen ![]() ![]() ![]() in Brain Stimulation (2018), 11(2), 459-461 Visuospatial neglect remains a relatively misunderstood complication of stroke. Up to 72% of right hemispheric strokes present neglect symptoms, and up to 75% of those patients still suffer at the 3-month ... [more ▼] Visuospatial neglect remains a relatively misunderstood complication of stroke. Up to 72% of right hemispheric strokes present neglect symptoms, and up to 75% of those patients still suffer at the 3-month mark. This leads to marked increases in dependency, and lower functional outcomes. Transcranial Direct Current Stimulation is a new rehabilitation tool that has been gaining popularity in the last two decades. Current research focuses on subacute or chronic strokes, while stimulating the posterior parietal cortex (PPC), and seems to have positive effects on visuospatial neglect. [less ▲] Detailed reference viewed: 49 (4 ULiège)![]() Bornheim, Stephen ![]() ![]() ![]() in Kinesitherapie Revue (2017, April), 184 Detailed reference viewed: 63 (24 ULiège)![]() GIFFROY, Xavier ![]() ![]() ![]() in Acta Neurologica Belgica (2017) The clinical variability and complexity of multiple sclerosis (MS) challenges the individual clinical course prognostication. This study aimed to find out whether multimodal evoked potentials (EP ... [more ▼] The clinical variability and complexity of multiple sclerosis (MS) challenges the individual clinical course prognostication. This study aimed to find out whether multimodal evoked potentials (EP) correlate with the motor components of multiple sclerosis functional composite (MSFCm) and predict clinically relevant motor functional deterioration. One hundred MS patients were assessed at baseline (T0) and about 7.5 years later (T1), with visual, somatosensory and motor EP and rated on the Expanded Disability Status Scale (EDSS) and the MSFCm, including the 9 Hole Peg Test and the Timed 25 Foot Walk (T25FW). The Spearman correlation coefficient (rS) was used to evaluate the cross-sectional and longitudinal relationship between EP Z scores and clinical findings. The predictive value of baseline electrophysiological data for clinical worsening (EDSS, 9-HPT, T25FW, MSFCm) during follow-up was assessed by logistic regression analysis. Unlike longitudinal correlations, cross-sectional correlations between EP Z scores and clinical outcomes were all significant and ranged between 0.22 and 0.67 (p\0.05). The global EP Z score was systematically predictive of EDSS and MSFCm worsening over time (all p\0.05). EP latency was a better predictor than amplitude, although weaker than latency and amplitude aggregation in the global EP Z score. The study demonstrates that EP numerical scores can be used for motor function monitoring and outcome prediction in patients with MS. [less ▲] Detailed reference viewed: 40 (12 ULiège)![]() Goffart, Nicolas ![]() ![]() in Neuro-Oncology (2017), 19(1), 66-77 BACKGROUND: Patients with glioblastoma (GBM) have an overall median survival of 15 months despite multimodal therapy. These catastrophic survival rates are to be correlated to systematic relapses that ... [more ▼] BACKGROUND: Patients with glioblastoma (GBM) have an overall median survival of 15 months despite multimodal therapy. These catastrophic survival rates are to be correlated to systematic relapses that might arise from remaining glioblastoma stem cells (GSCs) left behind after surgery. In this line, it has recently been demonstrated that GSCs are able to escape the tumor mass and preferentially colonize the adult subventricular zone (SVZ). At a distance from the initial tumor site, these GSCs might therefore represent a high-quality model of clinical resilience to therapy and cancer relapses as they specifically retain tumor-initiating abilities. METHOD: While relying on recent findings that have validated the existence of GSCs in the human SVZ, we questioned the role of the SVZ niche as a potential GSC reservoir involved in therapeutic failure. RESULTS: Our results demonstrate that (i) GSCs located in the SVZ are specifically resistant to radiation in vivo, (ii) these cells display enhanced mesenchymal roots that are known to be associated with cancer radioresistance, (iii) these mesenchymal traits are specifically upregulated by CXCL12 (stromal cell-derived factor-1) both in vitro and in the SVZ environment, (iv) the amount of SVZ-released CXCL12 mediates GBM resistance to radiation in vitro, and (v) interferes with the CXCL12/CXCR4 signalling system, allowing weakening of the tumor mesenchymal roots and radiosensitizing SVZ-nested GBM cells. CONCLUSION: Together, these data provide evidence on how the adult SVZ environment, through the release of CXCL12, supports GBM therapeutic failure and potential tumor relapse. [less ▲] Detailed reference viewed: 52 (22 ULiège)![]() BONHOMME, Vincent ![]() ![]() ![]() in Anesthesiology (2016), 125(5), 873-878 Background: Consciousness-altering anesthetic agents disturb connectivity between brain regions composing the resting-state consciousness networks (RSNs). The default mode network (DMn), executive control ... [more ▼] Background: Consciousness-altering anesthetic agents disturb connectivity between brain regions composing the resting-state consciousness networks (RSNs). The default mode network (DMn), executive control network, salience network (SALn), auditory network, sensorimotor network (SMn), and visual network sustain mentation. Ketamine modifies consciousness differently from other agents, producing psychedelic dreaming and no apparent interaction with the environment. The authors used functional magnetic resonance imaging to explore ketamine-induced changes in RSNs connectivity. Methods: Fourteen healthy volunteers received stepwise intravenous infusions of ketamine up to loss of responsiveness. Because of agitation, data from six subjects were excluded from analysis. RSNs connectivity was compared between absence of ketamine (wake state [W1]), light ketamine sedation, and ketamine-induced unresponsiveness (deep sedation [S2]). Results: Increasing the depth of ketamine sedation from W1 to S2 altered DMn and SALn connectivity and suppressed the anticorrelated activity between DMn and other brain regions. During S2, DMn connectivity, particularly between the medial prefrontal cortex and the remaining network (effect size β [95% CI]: W1 = 0.20 [0.18 to 0.22]; S2 = 0.07 [0.04 to 0.09]), and DMn anticorrelated activity (e.g., right sensory cortex: W1 = −0.07 [−0.09 to −0.04]; S2 = 0.04 [0.01 to 0.06]) were broken down. SALn connectivity was nonuniformly suppressed (e.g., left parietal operculum: W1 = 0.08 [0.06 to 0.09]; S2 = 0.05 [0.02 to 0.07]). Executive control networks, auditory network, SMn, and visual network were minimally affected. Conclusions: Ketamine induces specific changes in connectivity within and between RSNs. Breakdown of frontoparietal DMn connectivity and DMn anticorrelation and sensory and SMn connectivity preservation are common to ketamine and propofol-induced alterations of consciousness. [less ▲] Detailed reference viewed: 62 (20 ULiège)![]() ; ; Schmidt, Christina ![]() in Scientific Reports (2016), 6 Detailed reference viewed: 18 (4 ULiège)![]() VALDES SOCIN, Hernan Gonzalo ![]() ![]() ![]() in Annales d'Endocrinologie : 33ème congrès de la Société Française d'Endocrinologie (2016, October) Detailed reference viewed: 24 (5 ULiège)![]() ![]() Gaggioni, Giulia ![]() Conference (2016, September) Detailed reference viewed: 114 (13 ULiège)![]() ; Gaggioni, Giulia ![]() ![]() in Scientific Reports (2016), 6:33661 Detailed reference viewed: 42 (13 ULiège)![]() Muto, Vincenzo ![]() ![]() in Science (2016), 351(6300), Detailed reference viewed: 236 (37 ULiège)![]() ![]() Gaggioni, Giulia ![]() Conference (2016, June 15) Detailed reference viewed: 49 (8 ULiège)![]() GIFFROY, Xavier ![]() ![]() ![]() in BMC Neurology (2016) Functional biomarkers able to identify multiple sclerosis (MS) patients at high risk of fast disability progression are lacking. The aim of this study was to evaluate the ability of multimodal (upper and ... [more ▼] Functional biomarkers able to identify multiple sclerosis (MS) patients at high risk of fast disability progression are lacking. The aim of this study was to evaluate the ability of multimodal (upper and lower limbs motor, visual, lower limbs somatosensory) evoked potentials (EP) to monitor disease course and identify patients exposed to unfavourable evolution. One hundred MS patients were assessed with visual, somatosensory and motor EP and rated on the Expanded Disability Status Scale (EDSS) at baseline (T0) and about 6 years later (T1). The Spearman correlation (rS) was used to evaluate the relationship between conventional EP scores and clinical findings. Multiple (logistic) regression analysis estimated the predictive value of baseline electrophysiological data for three clinical outcomes: EDSS, annual EDSS progression, and the risk of EDSS worsening. In contrast to longitudinal correlations, cross-sectional correlations between the different EP scores and EDSS were all significant (0.33 ≤ rS < 0.67, p < 0.001). Baseline global EP score and EDSS were highly significant predictors (p < 0.0001) of EDSS progression 6 years later. The aseline global EP score was found to be an independent predictor of the EDSS annual progression rate (p < 0.001), and of the risk of disability progression over time (p < 0.005). Based on a ROC curve determination, we defined a Global EP Score cut off point (17/30) to identify patients at high risk of disability progression illustrated by a positive predictive value of 70 %. This study provides a proof of the concept that electrophysiology could be added to MRI and used as another complementary prognostic tool in MS patients. [less ▲] Detailed reference viewed: 40 (18 ULiège)![]() ![]() ; Muto, Vincenzo ![]() ![]() Poster (2016, June) Detailed reference viewed: 27 (4 ULiège)![]() ![]() DEMOULIN, Valentine ![]() ![]() Poster (2016, May 28) Detailed reference viewed: 18 (0 ULiège)![]() ![]() Jaspar, Mathieu ![]() ![]() Poster (2016, March 18) Detailed reference viewed: 34 (5 ULiège)![]() ![]() Gaggioni, Giulia ![]() ![]() Poster (2016, March 15) Detailed reference viewed: 83 (6 ULiège) |
||